← All trials
NCT01454323
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 31, 2010
- Primary completion
- Feb 28, 2015
- Completion date
- Feb 28, 2015
- First posted
- Oct 19, 2011
- Last posted
- Jun 30, 2015
- Enrollment
- 20
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Andalusian Initiative for Advanced TherapiesLead sponsor
- Andalusian Initiative in Advanced TherapiesCollaborator
- Universidad de CordobaOverall official - principal investigator
- Universidad de CordobaStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.